LYS006 |
Inhibitor of LTA4H
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| LTA4H |
|
|
Inhibitor
up to 200 nM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
LYS006 shows an exquisite selectivity profile when tested at concentrations of ≥10 μM in binding ...
Potency Cellular
In Vitro
LTA4H
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1021/acs.jmedchem.0c01955
In Vivo Validations
Mouse, Rat, Dog
Dose: 0.1, 1, 3 (IV) mg/Kg, 0.3, 3, 10 (PO) mg/Kg
Route of delivery:
Intravenous, Oral
Plasma half life:
16.7±5.3 (M), 169 (R), 48.8±4.3 (D) h
Systemic clearance:
4.2 (M), 0.66 (R), 0.94 (D) mL/min/Kg
DOI Reference: 10.1021/acs.jmedchem.0c01955
Negative Control Compounds
cpd 10
Chemical Information
| Molecular Formula | C16H14ClFN6O3 |
| SMILEs | N[C@@H](CC(=O)O)Cn1nnc(-c2ccc(Oc3ncc(Cl)cc3F)cc2)n1 |
| InChI | InChI=1S/C16H14ClFN6O3/c17-10-5-13(18)16(20-7-10)27-12-3-1-9(2-4-12)15-21-23-24(22-15)8-11(19)6-14(25)26/h1-5,7,11H,6,8,19H2,(H,25,26)/t11-/m0/s1 |
| Molecular weight | 392.08 Da |
| AlogP | 0.0 |
| HBond acceptors | 9 |
| HBond donors | 3 |
| Atoms | 41 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.